The following are a number of samples of Dr. Muscarella’s recently published white papers and guidance documents. A more detail listing of his peer-reviewed articles and other published papers is provided in his curriculum vitae, which is available upon request:
- Sterilization of Flexible Endoscopes: “Selection of Low-Temperature Sterilization for the Prevention of Multidrug-Resistant
Bacterial Infections During Flexible Endoscopy.” [April 2019; Sponsor: Ambu]
- Intubation Endoscopes and Multidrug-Resistant Bacteria: “Resistant Klebsiella Pneumoniae Infections Linked to Flexible Intubation Endoscopes: Recommendations to Prevent Infections.” [November 2018; Sponsor: Ambu]
- Other Flexible Endoscopes and CRE: “Risk of Flexible Endoscopes, Including Gastroscopes and Echo-endoscopes, Transmitting ‘Superbugs’ Infections — An Important Update.” [A white paper by L.F. Muscarella, PhD. April 2018; Sponsor: Ruhof]
- Gastrointestinal Endoscopes and CRE: “Updated Guidance for the Prevention of Transmission of ‘CRE’ and Other Related ‘Superbugs’ During Gastrointestinal Endoscopy.” [A white paper by L.F. Muscarella, PhD. November 2016; Sponsor: Ruhof]
- Bronchoscope Reprocessing: “Recommendations for resolving inconsistencies in the reprocessing instructions of bronchoscopies and automated reprocessors.” [Excerpt of a white paper by L.F. Muscarella, PhD. November 2016; Sponsor: Ambu]
Also read a few other articles by Dr. Muscarella:
- Bronchoscopy: “Bronchoscope-Related ‘Superbug’ Infections.” (Mehta AC, Muscarella LF. Chest 2020 Feb;157(2):454-469.
- Gastrointestinal Endoscopy: “Risk of transmission of carbapenem-resistant Enterobacteriaceae (CRE) and related ‘superbugs’ during gastrointestinal endoscopy”: World J Gastrointest Endosc 2014 Oct 16;6(10):457-74.
- Arthroscopy: “Other Possible Causes of a Well-Publicized Outbreak of Pseudomonas aeruginosa Following Arthroscopy in Texas“: Advances Infect Dis 2013 Jun;3(2).
- Central Lines: “Assessment of the Reported Effectiveness of Five Different Quality-Improvement Initiatives for the Prevention of Central Line-Associated Bloodstream Infections in Intensive Care Units”: Open Epidemiol J 2012;5:5-12.
- Medical Devices: “Infection-Control Breaches and the Use of Adulterated and Misbranded Medical Devices”: World J Clin Infect Dis 2012 Apr 25;2(2):13-27.
Contact Dr. Muscarella: Larry@LFM-HCS.com